NCT02568566View on ClinicalTrials.gov

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

May 19, 2016

Primary Completion Date

February 6, 2020

Study Completion Date

January 10, 2026

Conditions
Human Papillomavirus-Related Carcinoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Recombinant Human Papillomavirus Nonavalent Vaccine

Given IM

Trial Locations (2)

85719

Banner University Medical Center - Tucson, Tucson

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH